MSLN and ovarian carcinoma: In models such as ovarian cancer, analyses of correlation between MSLN expression, pathological variability and clinical outcomes indicated that high MSLN expression was positively associated with chemo-resistance in epithelial ovarian carcinoma patients and short patient survival time [12].